- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-01-0030659
_PRIVATE_LIMITED.webp)
About G.D. Laboratories (India) Private Limited
Data last updated:
G.D. Laboratories (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 March 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2001PTC306039. Its GSTIN is 08AABCG8519J1ZC (Rajasthan). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.95 Cr and a paid-up capital of ₹1.89 Cr. It is led by directors including Manik Chand Chachan and Ghanshyam Dass Chachan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 611 6th Floor Naurang House 21 K. G. Marg, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.81 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹63.89 Lakh (net margin 5.9%) and EBITDA of ₹1.44 Cr (EBITDA margin 13.3%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 7% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5.94 Cr and satisfied charges of ₹1.7 Cr on record. Court records list 6 cases involving the company, including 6 filed against it.
G.D. Laboratories (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0030659). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gdlab.co.in.
Company details
CIN history
G.D. Laboratories (India) has one previous CIN (Corporate Identification Number): U24233RJ2001PTC016915. The current CIN is U24233DL2001PTC306039, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233DL2001PTC306039 | Current |
| U24233RJ2001PTC016915 | Previous |
Recognitions & Rankings of G.D. Laboratories (India)
Contact details
G.D. Laboratories (India) Private Limited's registered office is in New Delhi, Delhi. Its website is gdlab.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address611 6th Floor Naurang House 21 K. G. Marg, New Delhi, Delhi, India – 110001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of G.D. Laboratories (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of G.D. Laboratories (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of G.D. Laboratories (India) Private Limited, buy the company report.
Financials of G.D. Laboratories (India) Private Limited
FY 2024 filings availableG.D. Laboratories (India) Private Limited reported revenue of ₹10.81 Cr (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.3% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of G.D. Laboratories (India) Private Limited, buy the company report.
Board of directors of G.D. Laboratories (India) Private Limited
G.D. Laboratories (India) has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manik Chand Chachan | Director | 13 Mar 2001 | 25 Years 7 Months | Current |
| Ghanshyam Dass Chachan | Director | 13 Mar 2001 | 25 Years 7 Months | Current |
| Mahabir Prasad Chachan | Director | 04 Aug 2021 | 5 Years 2 Months | Current |
| Rakesh Kumar Chachan | Director | 28 May 2006 | 20 Years 5 Months | Current |
Peer comparison
G.D. Laboratories (India) Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Badrivas Biotech Private Limited | ₹10.88 Cr (FY 2025) | 22.0% | New Delhi, Delhi, India | |||
| A.N.Pharmacia Laboratories Pvt Ltd. | ₹10.84 Cr (FY 2022) | 1.0% | Kolkata, West Bengal, India | |||
| G.D. Laboratories (India) Private Limitedthis company | ₹10.81 Cr (FY 2024) | ₹63.89 Lakh | 5.9% | -6.0% | 9 | New Delhi, Delhi, India |
| Ray Life Sciences Private Limited | ₹10.79 Cr (FY 2024) | 71.0% | Bangalore, Karnataka, India |
To see the full peer comparison of G.D. Laboratories (India) Private Limited, buy the company report.
Auditor
G.D. Laboratories (India) Private Limited is audited by MUKESH TULSYAN AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKESH TULSYAN AND ASSOCIATES | FY 2022 | 020445N |
Shareholding
The shareholding of G.D. Laboratories (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of G.D. Laboratories (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Oct 2024 | 101009093 | Bank of India | ₹2.63 Cr | Open | |
| 24 May 2023 | 100725854 | Hdfc Bank Limited | ₹30.36 Lakh | Open | |
| 22 Oct 2021 | 100512375 | Hdfc Bank Limited | ₹10.39 Lakh | Open | |
| 20 Dec 2019 | 100311831 | Others | ₹2.9 Cr | Open | |
| 20 Nov 2024 | 101002386 | Others | ₹40 Lakh | Satisfied |
To see the full charge records of G.D. Laboratories (India) Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
G.D. Laboratories (India) Private Limited has 6 court cases on record: 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 0 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (S) | Filed against the company by Ajanta Pharma Ltd | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ajanta Pharma Ltd | Disposed |
| Bombay High Court | Court case (LPETN) | Filed against the company by Ajanta Pharma Ltd | Disposed |
| District court, Mathura, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Cadila Healthcare Ltd | Disposed |
To see the full case history of G.D. Laboratories (India) Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
G.D. Laboratories (India) Private Limited has 3 MSME Form 1 returns on record between 2019 and 2021, listing 26 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 14)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Keshav Hichem Private Limited | |||
| Crown Art Printers | |||
| Hytech Printing Solutions Private Limited | |||
| Tarax Tech Private Limited | |||
| Rajat Vinyls Private Limited |
To see the full MSME payment records of G.D. Laboratories (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
G.D. Laboratories (India) Private Limited has a workforce of 9 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
GST
G.D. Laboratories (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AABCG8519J1ZC | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of G.D. Laboratories (India) Private Limited, buy the company report.
Recent activity
G.D. Laboratories (India) Private Limited has 6 board changes on record since 2001: 4 appointments and 2 cessations. The latest: Mahabir Prasad Chachan ceased to be Additional Director on 29 Sep 2023.
8 earlier events are in the company report.
Frequently asked questions
G.D. Laboratories (India) is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 March 2001 (25+ years old) and is registered under CIN U24233DL2001PTC306039.
G.D. Laboratories (India) has 4 current directors:
- Manik Chand Chachan - Director
- Ghanshyam Dass Chachan - Director
- Mahabir Prasad Chachan - Director
- Rakesh Kumar Chachan - Director
The latest financial statements of G.D. Laboratories (India) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of G.D. Laboratories (India) is 08AABCG8519J1ZC, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of G.D. Laboratories (India) is U24233DL2001PTC306039. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
G.D. Laboratories (India) has 6 court cases on record: 6 filed against it. Most are in the high courts.
G.D. Laboratories (India) was incorporated on 13 March 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of G.D. Laboratories (India) by revenue are Badrivas Biotech Private Limited, A.N.Pharmacia Laboratories Pvt Ltd, Ray Life Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mahabir Prasad Chachan ceased to be Additional Director on 29 Sep 2023. Mahabir Prasad Chachan was appointed as Director on 04 Aug 2021. Shakuntala Devi Chachan ceased to be Director on 15 Apr 2021. G.D. Laboratories (India) has 6 board changes on record in total.
Yes, G.D. Laboratories (India) is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0030659).
G.D. Laboratories (India) has 3 MSME Form 1 returns on record between 2019 and 2021, listing 26 overdue payments to 14 micro and small suppliers. The latest return was filed on 30 Aug 2021.
G.D. Laboratories (India) can be reached through the website gdlab.co.in. Its registered office is in New Delhi, Delhi, India.

